• Study of Glofitamab and Obinutuzumab for Patients with Relapsed or Refractory Lymphomas After CAR T-cell Therapy

    Not recruiting

    2 1 1 1
    Investigated drugs:
    France
  • Study on Seralutinib for Treating Pulmonary Arterial Hypertension in Patients

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia Denmark France Germany +10
  • Study on Long-term Safety and Effectiveness of Bimatoprost SR for Patients with Open-angle Glaucoma or Ocular Hypertension

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Poland Spain
  • Study on Extending Omalizumab Treatment Intervals for Adults with Well-Controlled Chronic Spontaneous Urticaria

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark
  • Study of pembrolizumab with gemcitabine and cisplatin as first treatment for patients with advanced or inoperable bile duct cancer

    Not recruiting

    3 1 1
    Investigated diseases:
    Belgium France Germany Ireland Italy The Netherlands +1
  • Study of Immunotherapy Combinations Including Zimberelimab for Patients With Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    France Italy Poland Spain
  • Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1 1
    Investigated diseases:
    Belgium Czechia France Germany Hungary Italy +3
  • Study on the Effectiveness and Safety of JNJ-77242113 for Treating Plaque Psoriasis in Special Areas for Patients with Moderate to Severe Symptoms

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Germany Hungary Poland Spain
  • Study on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment

    Not recruiting

    3 1 1
    Investigated diseases:
    Belgium Bulgaria Czechia Denmark France Germany +7
  • Study of Zipalertinib with Chemotherapy vs. Chemotherapy Alone for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Belgium Bulgaria France Germany Greece Italy +4

powered by